Beyond The Roundup | The NIH Updates Stance On Ivermectin | VIDEO

The National Institutes of Health (NIH) invited the Front Line COVID-19 Critical Care Alliance (FLCCC) to present to this national research agency’s COVID-19 Treatment Guidelines Panel. The Panel, which is the most influential of any such group worldwide, now is taking the time to review the unfolding Ivermectin situation. Of course, such a meeting wouldn’t be possible if it were not for the dedicated, committed and relentless efforts of the physician/researchers’ embrace of a story that we have been chronicling since April. The FLCCC, led by Dr. Pierre Kory and Dr. Paul Marik, along with prominent British researcher, Dr. Andrew Hill, affiliated with the University of Liverpool in the UK, presented their respective meta-analysis findings to date.
TrialSite News Related News Articles:
NIH Updates its COVID-19 Guidelines for Ivermectin While FLCCC Pays a Visit to Hugh HewittNIH COVID-19 Treatment Guidelines Panel Invites Top Ivermectin Researchers to Discuss the Evidence of Efficacy to Date

Reference Links:
WhiteboardDoctorDr. Kory radio interview:
Dr. Pierre Kory Of the FLCCC Alliance On The Therapeutic Value of Ivermectin in Treatment of Covid


Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee